AR123663A1 - Sistema de suministro de polímero biodegradable para la administración extendida de testosterona - Google Patents
Sistema de suministro de polímero biodegradable para la administración extendida de testosteronaInfo
- Publication number
- AR123663A1 AR123663A1 ARP210102729A ARP210102729A AR123663A1 AR 123663 A1 AR123663 A1 AR 123663A1 AR P210102729 A ARP210102729 A AR P210102729A AR P210102729 A ARP210102729 A AR P210102729A AR 123663 A1 AR123663 A1 AR 123663A1
- Authority
- AR
- Argentina
- Prior art keywords
- testosterone
- lactide
- molecular weight
- glycolide
- biodegradable polymer
- Prior art date
Links
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 title abstract 6
- 229960003604 testosterone Drugs 0.000 title abstract 3
- 229920002988 biodegradable polymer Polymers 0.000 title abstract 2
- 239000004621 biodegradable polymer Substances 0.000 title abstract 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 abstract 4
- 239000002202 Polyethylene glycol Substances 0.000 abstract 2
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229920001223 polyethylene glycol Polymers 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Composiciones poliméricas de poli(láctido-co-glicólido) (PLG) biodegradables que se administran al cuerpo con jeringas o agujas y que se utilizan para administrar testosterona al cuerpo durante un período de tiempo prolongado. Reivindicación 1: Una composición de liberación prolongada, caracterizada porque comprende: un ingrediente farmacéutico activo que comprende testosterona o un éster farmacéuticamente aceptable de la misma, en donde el ingrediente farmacéutico activo, antes de la suspensión en la composición farmacéutica, tiene un Dᵛ,₅₀ de aproximadamente 1 mm - aproximadamente 100 mm y un intervalo de aproximadamente 1 - aproximadamente 9; un sistema solvente que comprende un solvente biocompatible y un polietilenglicol (PEG) de bajo peso molecular que tiene un peso molecular medio en número de aproximadamente 3350 Daltons o menos; y un polímero biodegradable que comprende segmentos de copolímero de poli(láctido-co-glicólido) (PLG) que tiene una relación molar de monómeros de láctido a glicólido de aproximadamente 50:50 a aproximadamente 90:10, al menos un grupo terminal de ácido carboxílico, y un peso molecular medio en peso de aproximadamente 1 kDa - aproximadamente 45 kDa.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063085868P | 2020-09-30 | 2020-09-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR123663A1 true AR123663A1 (es) | 2022-12-28 |
Family
ID=78179467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210102729A AR123663A1 (es) | 2020-09-30 | 2021-09-30 | Sistema de suministro de polímero biodegradable para la administración extendida de testosterona |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240000797A1 (es) |
| EP (1) | EP4221684A1 (es) |
| JP (1) | JP2023544311A (es) |
| KR (1) | KR20230079071A (es) |
| CN (1) | CN116528876A (es) |
| AR (1) | AR123663A1 (es) |
| AU (1) | AU2021351927A1 (es) |
| BR (1) | BR112023005807A2 (es) |
| CA (1) | CA3197318A1 (es) |
| MX (1) | MX2023003800A (es) |
| TW (1) | TW202228707A (es) |
| WO (1) | WO2022070010A1 (es) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3708916A1 (de) | 1987-03-19 | 1988-09-29 | Boehringer Ingelheim Kg | Verfahren zur reinigung resorbierbarer polyester |
| DE19701912C1 (de) * | 1997-01-10 | 1998-05-14 | Jenapharm Gmbh | Injizierbares Implantat |
| WO2002012369A1 (fr) | 2000-08-07 | 2002-02-14 | Wako Pure Chemical Industries, Ltd. | Polymere d'acide lactique et son procede de preparation |
| ES2755374T3 (es) | 2007-02-15 | 2020-04-22 | Tolmar Therapeutics Inc | Poli(lactida/glicolida) de descarga lenta y métodos para producir polímeros |
| US20220040201A1 (en) * | 2018-09-25 | 2022-02-10 | Tolmar International, Ltd. | Liquid polymer delivery system for extended administration of drugs |
-
2021
- 2021-09-24 BR BR112023005807A patent/BR112023005807A2/pt unknown
- 2021-09-24 US US18/029,443 patent/US20240000797A1/en active Pending
- 2021-09-24 MX MX2023003800A patent/MX2023003800A/es unknown
- 2021-09-24 CA CA3197318A patent/CA3197318A1/en active Pending
- 2021-09-24 EP EP21791461.3A patent/EP4221684A1/en active Pending
- 2021-09-24 CN CN202180067408.9A patent/CN116528876A/zh active Pending
- 2021-09-24 KR KR1020237010987A patent/KR20230079071A/ko active Search and Examination
- 2021-09-24 WO PCT/IB2021/058743 patent/WO2022070010A1/en active Application Filing
- 2021-09-24 AU AU2021351927A patent/AU2021351927A1/en active Pending
- 2021-09-24 JP JP2023519653A patent/JP2023544311A/ja active Pending
- 2021-09-30 AR ARP210102729A patent/AR123663A1/es unknown
- 2021-09-30 TW TW110136529A patent/TW202228707A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021351927A9 (en) | 2024-09-26 |
| CN116528876A (zh) | 2023-08-01 |
| TW202228707A (zh) | 2022-08-01 |
| JP2023544311A (ja) | 2023-10-23 |
| MX2023003800A (es) | 2023-04-13 |
| AU2021351927A1 (en) | 2023-05-11 |
| US20240000797A1 (en) | 2024-01-04 |
| WO2022070010A1 (en) | 2022-04-07 |
| KR20230079071A (ko) | 2023-06-05 |
| CA3197318A1 (en) | 2022-04-07 |
| EP4221684A1 (en) | 2023-08-09 |
| BR112023005807A2 (pt) | 2023-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2009281223B2 (en) | Pharmaceutical compositions | |
| US11253504B2 (en) | Compositions of a polyorthoester and an aprotic solvent | |
| US7649023B2 (en) | Biodegradable block copolymeric compositions for drug delivery | |
| JP5043661B2 (ja) | 逆温度応答性ゲル化特性を有する生分解性ジブロック共重合体およびその使用方法 | |
| AU2009255675B2 (en) | Controlled release copolymer formulation with improved release kinetics | |
| KR20010083880A (ko) | 가역성 열 젤화 특성을 보유한 생분해성 저분자량 삼블록폴리에스테르 폴리에틸렌 글리콜 공중합체 | |
| JP2010144178A (ja) | 逆熱的ゲル化特性を有する生分解性低分子量トリブロックポリ（ラクチド−ｃｏ−グリコリド）−ポリエチレングリコールコポリマー | |
| KR101838304B1 (ko) | 향상된 방출 특성을 갖는 ｂａｂ 트리블록 중합체 | |
| RU2728786C2 (ru) | Фармацевтическая композиция с улучшенной стабильностью | |
| US7744919B2 (en) | Block copolymer micelle composition having an enhanced drug-loading capacity and sustained release | |
| ES2837149T3 (es) | Composiciones de un poliortoéster y un excipiente de ácido orgánico | |
| AR123663A1 (es) | Sistema de suministro de polímero biodegradable para la administración extendida de testosterona | |
| US10780175B2 (en) | Polymer systems and their applications in diagnostics and drug delivery | |
| Markland et al. | Biodegradable polymers as drug carriers | |
| AR123662A1 (es) | Composiciones y sistemas de polímeros y solventes biodegradables para un almacenamiento extendido y suministro de ingredientes farmacéuticos activos | |
| US20220118003A1 (en) | Pharmaceutical composition | |
| AR120120A1 (es) | Composiciones de polímero líquido y sistemas para la administración prolongada de péptidos como ingredientes farmacéuticos activos | |
| US20040147532A1 (en) | Liquid conjugates of solid pharmaceuticals | |
| Mohanty et al. | Biodegradable amphiphilic diblock copolymer as drug carriers | |
| EP2172189A1 (en) | Pharmaceutical Compositions | |
| NZ730538B2 (en) | Pharmaceutical composition with improved stability | |
| Woo Sun et al. | pH AND TEMPERATURE SENSITIVE BIODEGRADABLE BLOCK COPOLYMER HYDROGELS AND MICELLES FOR BIOMEDICAL APPLICATIONS | |
| Kobauri et al. | O11. NEW BIODEGRADABLE ABA TRIBLOCK AMPHIPHILIC COPOLYMERS AS MICELLAR NANOCARRIERS FOR SPARINGLY SOLUBLE PHARMACEUTICALS |